Ajanta Pharma USA recalls

4 recent recalls on record for Ajanta Pharma USA in connected official government data as of October 22, 2026 at 12:00 PM UTC.

Models with recalls

Aripiprazole Tablets USP (1)Fenofibrate Capsules (1)Fluphenazine Hydrochloride Tablets (1)Ranolazine Extended-Release Tablets (1)

All Ajanta Pharma USA recalls

FDA Class II · Drug · October 7, 2026

Ranolazine Extended-Release Tablets recall — Ajanta Pharma USA Inc

Failed Dissolution Specifications: below specification

Official ID D-0010-2027 · Official record ↗

FDA Class III · Drug · September 16, 2026

Fluphenazine Hydrochloride Tablets recall — Ajanta Pharma USA Inc

Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 …

Official ID D-0836-2026 · Official record ↗

FDA Class II · Drug · July 1, 2026

Fenofibrate Capsules recall — Ajanta Pharma USA Inc

CGMP Deviations

Official ID D-0611-2026 · Official record ↗

FDA Class II · Drug · June 24, 2026

Aripiprazole Tablets USP recall — Ajanta Pharma USA Inc

Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.

Official ID D-0594-2026 · Official record ↗

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked October 22, 2026 at 12:00 PM UTC.